Earn 40 Category 1 CME Credits for $199

Directions in Psychiatry Special Offer $199
Directions in Psychiatry Special Offer $199
Item# DP36199A
Standard Course Fee: $300.00
Your Special Price: $199.00
Format: 

Course Description

Everyone needs continuing education. But who needs to be overwhelmed by it?

For more than 30 years, Directions in Psychiatry remains the pre-eminent continuing medical education program for psychiatrists world-wide.

Concise, essential, authoritative and timely, Directions in Psychiatry has delivered on the promise of insightful and useful information that psychiatrists world-wide need to stay current and earn CME requirements. Directions in Psychiatry keeps you up-to-date as you earn 40 AMA PRA Category 1 CME Credits annually in the comfort of your home or office.

Submit your test answers via our online test submission module, a convenient way to get your CME work done from home, office, vacation or while traveling.

VIEW A SAMPLE ISSUE:



CME BENEFITS & AWARDS:
  • 40 AMA PRA Category 1 CME Credits
  • ABPN Approved
  • 20 Essential Lessons
  • Convenient Digital Delivery Option
  • Permanent Record of CME Activities
  • Top Faculty from Leading Institutions
  • Online Quiz Submission
  • Designed for Rapid Learning
  • Abstract for Instant Review
  • Toll-free customer service support

    Digital Option: Coursework will be sent to you via email within 24 hours.
    Print Option: Coursework will be sent to you via USPS Priority Mail.


    Directions in Psychiatry at a Glance
    Lessons: 20 per volume
    CME Credits: 40 Category 1 CME credits
    Multiple-Choice Questions: 4 per lesson
    Estimated Time to complete each Lesson: 2 hours
    Approvals: ACCME, ABPN
    Duration of Program: 12-36 months
    Expert Faculty
    All Lessons Are Peer Reviewed
    Editor's Note with Learning Objectives



    CME Course Content:


  • PTSD: Overview and DSM-5 Changes
  • Substance Use Disorders: An Overview, and Changes in the DSM-5
  • Somatic Symptoms and Related Disorders: Overview, Updates, and Changes in the DSM-5
  • The Meaning of Despair: Existential and Spiritual Dimensions of Depression and Its Treatment
  • The Detrimental Impact of Maladaptive Personality on Public Mental Health: A Challenge for Psychiatric Practice
  • Treatment of U.S. Military Soldiers and Veterans: Basics of PTSD, Administrative Issues, and Cultural Competency
  • Meeting the Psychosocial Needs of Burn Survivors and Their Families
  • Synthetic Cathinone and Cannabinoid Designer Drugs
  • Closing the Treatment Gap for Mental, Neurological and Substance Use Disorders by Strategies for Delivery and Integration of Evidence‐based Interventions
  • Recent Advances in Psychological Therapies for Eating Disorders
  • Psychiatrists as Expert Witnesses
  • Acute Ischemic Stroke, Post-stroke, Cognitive Deficits, and Depression
  • Intellectual Disability Disorder (IDD): From the DSM-IV-TR to the DSM-5
  • Attention-Deficit Hyperactivity Disorder: Overview and DSM-5 Changes
  • Dissociative Disorders: Between Neurosis and Psychosis
  • The “Three Buckets” Model for Treating Stress Disorder (PTSD): Medication, Therapy, and Everything Else
  • Chronic Pain, Cognitive Deficits, and Depression
  • Biomarkers in Alzheimer’s Disease
  • Substance Use During Pregnancy
  • Knowledge Transfer in the Field of Parental Illness: Objectives, Effective Strategies, Indicators of Success, and Sustainability




  • Accreditation Statement
    ACCME
    The Hatherleigh Company, Ltd. is accredited by the ACCME to provide continuing medical education for physicians.

    The Hatherleigh Company, Ltd. designates the Directions in Psychiatry continuing medical education program for 40 credit hours in "Category 1 of the Physician's Recognition Award of the American Medical Association".

    This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). The Hatherleigh Company, Ltd. takes responsibility for the content, quality, and scientific integrity of this CME Activity.

    ABPN
    For the American Board of Psychiatry & Neurology, this activity awards up to 40 Self-Assessment Category 1 CME credits. The approval period is for January 1, 2017 – January 1, 2020.